HINT1 and amyotrophic lateral sclerosis: Thus, HINT1 mutants may promote α2δ1 and σ1R mediated activation of NMDARs, and accordingly, amyotrophic lateral sclerosis could be treated with drugs reducing NMDAR activity [55].